We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Installation of First High-Field MRI-Guided Linear Accelerator Completed

By HospiMedica International staff writers
Posted on 10 Nov 2015
A leading Imaging vendor, and a company creating clinical solutions for treating cancer and brain disorders, has installed the first high-field (1.5 T) MRI-guided linear accelerator in a US hospital.

The accelerator, intended for nonclinical use, was installed at the University of Texas MD Anderson Cancer Center (Houston, Texas, USA) and will begin operation in early 2016. More...
The world’s first high-field Magnetic Resonance Imaging (MRI)-guided linear accelerator (MR linac) was installed at the University Medical Center Utrecht (UMC; Utrecht, Netherlands) 2014.

The accelerator, which was developed by Philips (Amsterdam, the Netherlands) and Elekta (Stockholm, Sweden), can capture highly-detailed MR images during radiotherapy, showing tumors and surrounding healthy tissue. The images can help researchers adjust the delivery of treatments, the accuracy of therapies, and improve the outcome for patient treatments.

Stephen Hahn, MD, MD Anderson’s Radiation Oncology division, said, “The installation of the MR linac is going well and an example of the cooperation between MD Anderson, Elekta and Philips. We expect to have the first nonclinical beam in January 2016. The MD Anderson Division of Radiation Oncology is excited about the opportunities that the MR linac project is targeted to provide to our patients. The possibility of soft tissue imaging combined with advanced radiation delivery in a linac could allow us to provide improved value for our patients.

Related Links:

University of Texas MD Anderson Cancer Center
UMC Utrecht
Philips



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.